Cytek Biosciences Inc
NASDAQ:CTKB

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
NASDAQ:CTKB
Watchlist
Price: 6.55 USD 0.92% Market Closed
Market Cap: 843.7m USD
Have any thoughts about
Cytek Biosciences Inc?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-35
Current
-20.6
Median
18.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-35
=
Enterprise Value
585.5m USD
/
EBITDA
-16.7m USD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
25.2
2-Years Forward
EV/EBITDA
15.6
3-Years Forward
EV/EBITDA
13

See Also

Discover More